AACR

Exact Sciences showcases early cancer detection test data at AACR meeting
Clinical Trials Arena
Fri, 11/15/24 - 11:13 am
Medtech
diagnostics
EXACT Sciences
biomarkers
cancer
MCED
AACR
Vaccines, next-gen approaches target the toughest cancers: AACR
BioSpace
Fri, 04/12/24 - 11:36 am
cancer
oncology
AACR
vaccines
AACR: Study Suggests Accelerated Approval Doesn’t Always Lead to Clinical Benefit
BioSpace
Wed, 04/10/24 - 05:44 pm
AACR
oncology
FDA
accelerated approvals
AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer
BioSpace
Wed, 04/10/24 - 09:59 am
Merck
Kelun-Biotech
SKB264
gastric cancer
antibody-drug conjugate
clinical trials
AACR
The Next Wave of ADCs Could Treat Evasive Solid Tumors
BioSpace
Mon, 04/8/24 - 11:57 am
antibody-drug conjugate
AACR
solid tumors
Elevation Oncology
Tubulis
Pfizer donates rights to cancer drug
Beckers Hospital Review
Wed, 12/13/23 - 09:39 am
Pfizer
Bavencio
AACR
cancer
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
CAR-T
Bristol Myers Squibb
JNJ
Legend Biotech
AACR
Multiple Myeloma
Carvykti
Abecma
Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting
BioSpace
Wed, 04/19/23 - 11:21 am
Bridge Biotherapeutics
BBT-207
AACR
non-small cell lung cancer
AACR 2023 – Hippo makes a splash
EP Vantage
Wed, 04/19/23 - 10:07 am
Vivace Therapeutics
VT3989
AACR
Novartis
Sanofi
Ikena Oncology
AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field 'much less crowded than it seems'
Fierce Biotech
Tue, 04/18/23 - 10:18 pm
Eli Lilly
Amgen
Mirati Therapeutics
KRAS inhibitors
AACR
REGN5459 Delivers Dose-Dependent Responses in Relapsed/Refractory Myeloma
Onc Live
Tue, 04/18/23 - 09:49 am
Regeneron
AACR
REGN5459
relapsed or refractory multiple myeloma
Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple combination
BioSpace
Mon, 04/17/23 - 11:21 am
Medivir
AACR
fostrox
cancer
AACR: Patient deaths taint Roche's industry-first early-stage liver cancer readout for Tecentriq and Avastin
Fierce Pharma
Sun, 04/16/23 - 11:26 pm
Roche
AACR
liver cancer
patient deaths
AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate
Fierce Pharma
Sun, 04/16/23 - 11:22 pm
AstraZeneca
AACR
Imfinzi
non-small cell lung cancer
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
AACR
Moderna Therapeutics
Allogene
AstraZeneca
Merck
Roche
Novartis
Eli Lilly
Innovent
Springworks
Biogene
Relay Therapeutics
Vivace Therapeutics
AACR: AbbVie's navitoclax goes after tough blood cancer, not yet reaching overall survival benchmark
Fierce Biotech
Tue, 04/12/22 - 08:31 pm
AACR
AbbVie
navitoclax
myelofibrosis
blood cancer
Novartis Highlights Early Data from Potential Lumakras Competitor at AACR
BioSpace
Tue, 04/12/22 - 10:49 am
Novartis
AACR
JDQ443
clinical trials
Amgen
Lumakras
AACR 2022 – A weekend of updates yields few winners
EP Vantage
Tue, 04/12/22 - 10:34 am
AACR
Bicycle Therapeutics
Rubius Therapeutics
C4 Therapeutics
Zentalis
Affimed
Seagen
Astellas
BrickBio Debuts Powerful Advantage of Novel ADCs, Protein Origami, and Synthetic Virology at 2022 AACR
BioSpace
Mon, 04/11/22 - 10:56 am
BrickBio
antibody-drug conjugate
protein origami
AACR
Bicycle Therapeutics shares fall 23% after the company shares interim Phase 1 data
Marketwatch
Mon, 04/11/22 - 10:39 am
AACR
Bicycle Therapeutics
clinical trials
urothelial cancer
BT8009

Pages